Thank you very much for visiting the 13th annual Business of Biosimilars & Generic Drugs conference! Our 2012 event was a major success, and we are glad to have been able to offer our audience all-new case studies representing the introduction of biosimilars to multiple global markets. This was our most internationally-focused conference yet, featuring market analyses from China, South Korea, Mexico, Turkey, Vietnam, Syria, and Saudi Arabia, among others. Other major issues in this field include the formation of strategic mega-partnerships such as Samsung Bioepis, and also the pinpointing of areas of shared learning and opportunity between biologics and generic drug companies.
For more information about upcoming events on the follow-on biopharmaceutical industry makes sure to sign up for e-mail updates.